A Layered Business Case, annotated

This row leads ROI because it is the only one with hard customer data behind it: 65% participation when the partner co-managed the baseline survey, against an industry default closer to 40–50%. The number is the customer’s own.

The framing is deliberately upstream. Participation is not a benefit in itself — it is the foundation of every downstream decision in the programme. A row about participation rate signals that the supplier is thinking about the quality of the diagnosis, not just the cost of the intervention.

Confidence is set at 70%, not higher, because attributing the full economic value to the partner rather than to internal factors requires some discount.

The customer’s language was “too expensive AND not effective.” That phrase is preserved verbatim. The value-item label translates it into procurement language without losing its meaning.

This is the vocabulary discipline that separates an LBC that survives procurement from one that doesn’t. Words the buying coalition recognises from their own conversations travel into the procurement file. Supplier vocabulary triggers the reflex to discount the claim.

The €60,000 figure assumes 60% of the prevention budget is spent on generic interventions the customer has called ineffective. The 70% upside is conservative — the partner can shift the spend, but cannot recover historical waste.

Most business cases ignore the cost of delay because it is a counterfactual — the customer cannot point to the money lost. The discipline is to make the counterfactual visible.

If the diagnostic phase takes six months longer than necessary, the issues the survey identified stay unaddressed for those months. The cost of unresolved wellbeing issues is roughly proportional to the cost of the underlying problem. Six months of that, at the hospital’s scale, is a real number.

The supplier brings this row because the discipline of the Layered Business Case is to bring rows the customer would not have constructed alone.

This row used to sit in the Lifecycle layer. It now sits in ROI — and the contrast with the re-tendering row in Strategic is the whole point.

Coordination cost is genuinely operational: the HR Director, managers, board, procurement, and partner all spend hours aligning on the programme. Hours times blended hourly cost, recurring annually — exactly the shape of any other ROI line.

So the two former Lifecycle rows split in two directions. One was a positioning argument and went to Strategic; this one was an operational saving and stayed in ROI. That split is why Lifecycle could be dropped without losing anything — it was always doing two jobs the other layers already covered.

The €200,000 cost-at-risk is the largest single number in the case. It is also the number that would attract the most CFO scrutiny.

The 40% upside is conservative: the partnership reduces illness cost at the margin, it does not eliminate it. The 40% confidence reflects the difficulty of attributing absence reduction to the partner rather than to seasonal illness, internal HR initiatives, or broader labour-market dynamics.

The risk-adjusted €32,000 is therefore far smaller than the headline €200,000. That gap is the cost of honesty. The €32,000 is defensible to a CFO; the €200,000 would not survive the first challenge. A supplier who over-claims here is discounted on every other row.

The customer’s own position frames this row: “There is more to be gained from preventing someone falling out than from reintegrating them after.” That sentence is the commercial argument for proactive prevention, and it belongs in the case in the customer’s words.

The economic asymmetry is real. A reintegration case — agency staffing, knowledge loss, manager coordination, the reintegration process itself — runs to multiples of a preventive intervention. The 50% upside reflects the gap between the two cost trajectories.

Confidence is 50%: the case for prevention as a category is strong; the case for any single intervention preventing any single burnout is weak. Naming that in the confidence figure protects the row.

This row exists because of one moment in the customer interview: the lead internal HR person fell ill mid-survey, the partner stepped in to co-manage, and participation hit 65% anyway. A documented case of the partnership absorbing organisational shock.

Resilience rows are usually missing from B2B cases because resilience is hard to quantify in advance. The trick is to find the moment in the customer’s history when the partnership absorbed a shock the customer could not have absorbed alone, and use it as the evidence base.

Without this row, the partnership reads as a service contract. With it, it reads as operational resilience. The board hears those two propositions very differently.

The HR Director’s most pressing strategic problem is the annual defence of the wellbeing budget at board level. Without board-level impact reporting, the budget is vulnerable to every cost-cutting cycle.

The €75,000 is roughly the proportion of the annual prevention budget at risk on any given board cycle without strong impact reporting. The 70% upside reflects the partner’s ability to provide the reporting; the customer still has to make the case internally.

This is the most defensible Strategic argument because the customer named the problem in their own words: the wish to express illness costs to make wellbeing tangible. The row operationalises the customer’s own ask.

A specialist supplier operating across many organisations sees regulatory and societal change earlier than any one customer can. The supplier sits across the sector; the customer sits in one organisation. That asymmetry of vantage is a commercial asset.

For the hospital, the value is in not being late on changes other employers are also adjusting to — reintegration law, aggression-prevention requirements, the data and AI components of wellbeing measurement. A partner who flags a change 12 months ahead lets the hospital prepare; 3 months ahead forces it to react.

The €30,000 is conservative. The cost of a missed regulatory change, in compliance retrofitting and reputational exposure, can run much higher.

The Belgian healthcare labour market is structurally tight. Recruiting a nurse takes months, costs four to six figures including agency fees, and increasingly fails because the candidate joins a different employer. A weak internal wellbeing reputation pushes an employer down candidates’ preference order.

The partnership produces an employer-brand effect that is real but hard to attribute. Improved retention reduces churn and signals to the market that people stay. Both effects are valuable.

The figure is €50,000 at 50% confidence — small enough to defend, large enough to matter. A higher figure invites a challenge on attribution.

This row used to sit in the Lifecycle layer. It now sits in Strategic, and the move is the more interesting half of the story.

A tender process involves HR, the Board, procurement, legal, and the programme’s operational leadership — tens of thousands of euros per tender. But this is a Strategic row, not an operational one, because the cost is really about positioning: a compliance-vendor relationship forces a tender every cycle, while a strategic-partner relationship turns renewal into a conversation. The customer is buying out of the recurring exposure of being in the wrong kind of relationship.

That is why it belongs next to the other Strategic arguments — board legitimacy, early signalling, employer reputation — and not in operational ROI.

The €80,000 is not the cost across all 3,000 employees. It is the cost across the pressured operational teams — nursing, emergency, intensive care — where the effects concentrate. Applying it organisation-wide would inflate the figure and damage credibility.

This is the discipline of segmentation within a row. The LBC is not a list of organisation-wide averages; it is a structured argument about where value leaks and where the partnership stops the leak. Naming the affected teams sharpens the row.

Confidence is 40% because the partnership reduces but cannot eliminate technostress and aggression, and attribution is partial. The €12,800 headline is small but defensible.

Connection and engagement are hard to quantify precisely. The temptation is to leave the row qualitative — “stronger connection improves effectiveness” — without a number.

The discipline is to find a defensible proxy. Here it is the cost of weak engagement expressed as attrition risk: an at-risk employee represents a recruitment cost, a training cost, and a productivity dip. Multiply by affected employees, apply a conservative improvement percentage.

The number is not precise. It does not need to be. It needs to be defensible — explainable in one sentence, conservative, and clearly distinguished from the harder ROI rows.

This row sits last in the People layer but is structurally upstream of all of them. Mid-level managers carry the wellbeing intervention point on every team. If they cannot translate the survey data and the programme, the whole partnership stops at the office door of the people who need it most.

The €40,000 reflects the cost of weak people management in pressured teams — extra HR interventions, escalations, manager turnover. The 50% upside reflects equipping managers, not replacing them.

This is also where the buying coalition expands. The HR Director buys, but managers are users who become advocates if the partnership works for them, and detractors if it doesn’t. A row managers recognise as theirs protects the partnership at renewal.